Transplantation with standard-criteria kidney offers a clear survival benefit, but this decreases with age and for those with ...

The FDA has approved Widaplik (telmisartan, amlodipine and indapamide) for the treatment of hypertension, including as initial treatment, to lower blood pressure.

Semaglutide use may be increasing worldwide rates of ischemic optic neuropathy and retinal adverse events, a study suggests.

The risk of cardiotoxicity may vary across CDK4/6 inhibitors, according to a study of patients with breast cancer.

Patients with lower extremity acute limb ischemia who receive computer-assisted vacuum thrombectomy have significantly lower complication rates.

Cessation of public water fluoridation would increase tooth decay and health system costs in the United States.

In patients with moderate peripheral artery disease, use of GLP-1 RAs increases the likelihood of more favorable cardiovascular and major limb outcomes.

Dr Martin J Tobin discusses health disparities related to pulse oximeter accuracy and the need for improvement to make health care equitable.

Access to patient portals increases the likelihood that patients with or at risk for cardiovascular disease will engage in shared decision-making.

Patients with T1D experienced greater reductions in risk for cardiovascular disease with empagliflozin compared with placebo.

Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.

Topline data were announced from two phase 3 trials evaluating enlicitide decanoate for the treatment of adults with hyperlipidemia.